PROCTER & GAMBLE HEALTH | THEMIS MEDICARE | PROCTER & GAMBLE HEALTH/ THEMIS MEDICARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 71.9 | 48.1% | View Chart |
P/BV | x | 10.6 | 5.9 | 179.9% | View Chart |
Dividend Yield | % | 2.0 | 0.2 | 869.9% |
PROCTER & GAMBLE HEALTH THEMIS MEDICARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
THEMIS MEDICARE Mar-23 |
PROCTER & GAMBLE HEALTH/ THEMIS MEDICARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,434 | 374.1% | |
Low | Rs | 3,883 | 692 | 561.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 385.1 | 192.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 61.8 | 223.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 73.3 | 211.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.50 | 19,000.0% | |
Avg Dividend yield | % | 2.1 | 0 | 4,368.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 368.9 | 121.3% | |
Shares outstanding (eoy) | m | 16.60 | 9.20 | 180.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.8 | 226.1% | |
Avg P/E ratio | x | 33.5 | 17.2 | 194.5% | |
P/CF ratio (eoy) | x | 29.8 | 14.5 | 205.3% | |
Price / Book Value ratio | x | 10.3 | 2.9 | 358.3% | |
Dividend payout | % | 68.7 | 0.8 | 8,498.1% | |
Avg Mkt Cap | Rs m | 76,761 | 9,784 | 784.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 661 | 311.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,543 | 347.0% | |
Other income | Rs m | 184 | 115 | 159.8% | |
Total revenues | Rs m | 12,480 | 3,658 | 341.1% | |
Gross profit | Rs m | 3,247 | 811 | 400.5% | |
Depreciation | Rs m | 281 | 105 | 267.7% | |
Interest | Rs m | 8 | 96 | 8.1% | |
Profit before tax | Rs m | 3,142 | 725 | 433.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 156 | 542.7% | |
Profit after tax | Rs m | 2,295 | 569 | 403.3% | |
Gross profit margin | % | 26.4 | 22.9 | 115.4% | |
Effective tax rate | % | 27.0 | 21.5 | 125.2% | |
Net profit margin | % | 18.7 | 16.1 | 116.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 2,748 | 426.3% | |
Current liabilities | Rs m | 6,791 | 1,494 | 454.6% | |
Net working cap to sales | % | 40.0 | 35.4 | 113.1% | |
Current ratio | x | 1.7 | 1.8 | 93.8% | |
Inventory Days | Days | 263 | 87 | 301.4% | |
Debtors Days | Days | 343 | 1,494 | 23.0% | |
Net fixed assets | Rs m | 10,617 | 2,494 | 425.7% | |
Share capital | Rs m | 166 | 92 | 180.4% | |
"Free" reserves | Rs m | 7,265 | 3,302 | 220.0% | |
Net worth | Rs m | 7,431 | 3,394 | 218.9% | |
Long term debt | Rs m | 0 | 284 | 0.0% | |
Total assets | Rs m | 22,330 | 5,242 | 426.0% | |
Interest coverage | x | 409.1 | 8.6 | 4,766.4% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.7 | 81.5% | |
Return on assets | % | 10.3 | 12.7 | 81.3% | |
Return on equity | % | 30.9 | 16.8 | 184.2% | |
Return on capital | % | 42.4 | 22.3 | 190.0% | |
Exports to sales | % | 0 | 39.4 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 1,395 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 1,395 | 105.0% | |
Fx outflow | Rs m | 1,605 | 477 | 336.3% | |
Net fx | Rs m | -140 | 918 | -15.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 161 | 1,466.5% | |
From Investments | Rs m | -215 | -240 | 89.7% | |
From Financial Activity | Rs m | -985 | 1 | -72,404.4% | |
Net Cashflow | Rs m | 1,160 | -77 | -1,500.5% |
Indian Promoters | % | 0.0 | 57.5 | - | |
Foreign collaborators | % | 51.8 | 9.6 | 539.2% | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 49,925.0% | |
FIIs | % | 6.2 | 0.0 | 20,800.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 32.9 | 146.7% | |
Shareholders | 56,778 | 11,295 | 502.7% | ||
Pledged promoter(s) holding | % | 0.0 | 2.8 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | THEMIS MEDICARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 2.58% | 0.45% |
1-Month | -1.15% | -3.13% | 2.55% |
1-Year | 0.73% | -85.92% | 56.14% |
3-Year CAGR | -8.76% | -16.55% | 15.22% |
5-Year CAGR | 4.97% | -5.37% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the THEMIS MEDICARE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of THEMIS MEDICARE the stake stands at 67.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of THEMIS MEDICARE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
THEMIS MEDICARE paid Rs 0.5, and its dividend payout ratio stood at 0.8%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of THEMIS MEDICARE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.